Skip to content

Comparison of Combined (Superficial and Deep) and Isolated Deep Serratus Anterior Plane Blocks After Breast Surgery

Investigation of the Effectiveness of Ultrasonography-Guided Deep Serratus Anterior Plane Block and Combined Superficial and Deep Serratus Anterior Plane Block on Postoperative Pain in Patients Undergoing Modified Radical Mastectomy and Breast-Conserving Surgery

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07724678
Enrollment
76
Registered
2026-07-24
Start date
2025-04-21
Completion date
2026-05-18
Last updated
2026-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, Pain Management After Surgery, Postoperative Pain

Keywords

Serratus Anterior Plane Block, Regional Anesthesia, Bupivacaine, Breast Surgery, Analgesia

Brief summary

The main purpose of this study is to compare the effectiveness of two different regional anesthesia techniques for pain management after oncological breast surgeries. The researchers will compare the combined (superficial and deep) serratus anterior plane block with the deep serratus anterior plane block. The study aims to evaluate which method provides better postoperative pain relief, reduces the total consumption of opioid analgesics, and improves patient comfort

Interventions

None listed

Sponsors

SBU Ankara Egitim ve Arastirma Hastanesi
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

Patients aged 18-80 years. Female patients with ASA physical status I, II, or III. Patients scheduled for elective modified radical mastectomy or breast-conserving surgery. Patients who provided written and verbal informed consent.

Exclusion criteria

Patients with ASA physical status IV-V. Patients with a BMI ≥ 35 kg/m². Patients with chronic pain, opioid/substance addiction, or long-term analgesic use. Patients requiring emergency surgery. Pregnant patients. Known allergy to local anesthetics. Severe cardiovascular, cerebrovascular, liver, or renal disease. History of coagulopathy. Infection at the injection site or systemic infection. Patients who refuse the regional anesthesia technique, cannot speak the official language, or have mental disabilities/inability to cooperate. Patients with a history of previous breast surgery or those scheduled for bilateral operations.

Design outcomes

Primary

MeasureTime frameDescription
Visual Analog Scale (VAS) Scores for Postoperative PainPostoperative 24 hours.Assessment of postoperative pain using the Visual Analog Scale (VAS) (minimum score: 0, maximum score: 10, where higher scores indicate worse outcome).

Secondary

MeasureTime frameDescription
Total Tramadol ConsumptionPostoperative 24 hours.Total amount of tramadol consumed by the patient as rescue analgesia.
Need for rescue analgesiaPostoperative 24 hours.Requirement for additional analgesic medications beyond the standard protocol.
Time to first rescue analgesiaPostoperative 24 hours.Time elapsed from the end of surgery until the first request for rescue analgesia.
Postoperative nausea and vomiting (PONV) scoresPostoperative 24 hours.Assessment of postoperative nausea and vomiting severity.
Patient satisfactionPostoperative 24 hours.Patient satisfaction level regarding the pain management technique.
Block-related complicationsPostoperative 24 hours.Incidence of potential complications related to the block technique (e.g., hematoma, infection, local anesthetic toxicity).

Countries

Turkey (Türkiye)

Contacts

STUDY_DIRECTORMeltem Bektas, Associate Professor

SBU Ankara Egitim ve Arastirma Hastanesi

STUDY_DIRECTORDilara Hatice Arican, MD

SBU Ankara Egitim ve Arastirma Hastanesi

PRINCIPAL_INVESTIGATORCemre Kahya Özgünalp, MD

SBU Ankara Egitim ve Arastirma Hastanesi

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 5, 2026